We use third-party cookies in order to personalize your site experience. See our Privacy Policy.

Technology thesis · Biotechnology & Health

medium conviction growth

Digital health and telemedicine

Telemedicine pure-plays stay structurally weak; the value has migrated to ambient AI scribes (Abridge, Suki) and employer-paid MSK/chronic care (Hinge, Sword), with the Medicare cliff deferred to 2027.

Position maintained continuously · last reviewed Jun 24, 2026

The thesis

Core thesis

COVID forced telemedicine adoption, but post-pandemic usage settled at a modest 12–17% of outpatient visits, concentrated in mental health and chronic care rather than acute care. The durable value has migrated off the pure-play visit platforms (Teladoc, Amwell) into two adjacencies: ambient AI clinical documentation (Abridge, Suki, Nabla, Microsoft Nuance DAX), the fastest-adopting clinical AI to date, and employer-paid musculoskeletal and chronic care (Hinge Health, Sword Health). The next layer is agentic AI – triage, RPM feeding AI, and AI primary-care agents (Hippocratic AI, K Health). The EU AI Act classifies AI-assisted diagnosis as high-risk, adding a compliance drag on European deployment.

State of the art (2026)

The 2020-21 telemedicine boom has bifurcated. Pure-play visit platforms (Teladoc, Amwell) remain structurally challenged, while the value has migrated to two adjacencies. First, ambient AI documentation: Abridge, now leader after a $300m Series E in June 2025 at a $5.3bn valuation on the back of deep Epic integration, plus Suki, Nabla and Microsoft Nuance DAX, is the fastest-adopting clinical AI to date. Second, employer-paid musculoskeletal and chronic care: Hinge Health (HNGE) listed in May 2025 and Sword Health continue to scale. The defining 2026 event was regulatory – Medicare telehealth flexibilities lapsed at the October 2025 shutdown, then were extended through December 2027 by the February 2026 spending package, removing the annual cliff but not making parity permanent.

The rest of the file

Everything below is live inside CanaryIQ

The full analysis behind the verdict — the structure is real; the content unlocks when you log in.

Signal stack

Evidence stacked leading → lagging

10 signals
talent
research
patent
expert
operational
regulatory
market

Technology-native KPIs

Metrics that predict trajectory, tracked over time

3 tracked
Telehealth visit share of outpatient encounters
Remote patient monitoring users
Digital health funding (US VC, Rock Health)

Landscape map

Who builds what — and who depends on whom

193 players · 6 layers

Catalyst calendar

Dated events that will move the position

5 ahead

Technology roadmap

Milestones on the path to maturity

8 milestones

Watchlists

Companies, people and papers — each with a remove-by condition

20 · 20
Companies · 20
People · 20

Decision frameworks

The same call, framed for your desk

Locked
Public Equity
PE / VC
Corporate Leader

Thesis changelog

When our view changed, and why

5 updates

Change our mind

3 disconfirming conditions

The rest is inside

You've read the verdict. The file is much deeper.

The full signal stack, technology-native KPIs tracked over time, the landscape of who depends on whom, the dated catalyst calendar, decision frameworks for every desk, live watchlists and the changelog of every time our call on Digital health and telemedicine has changed — all live inside CanaryIQ.